NATCO Pharma Limited NATCOPHARM.NS Stock
NATCO Pharma Limited Price Chart
NATCO Pharma Limited NATCOPHARM.NS Financial and Trading Overview
| NATCO Pharma Limited stock price | 975 INR |
| Previous Close | 639.55 INR |
| Open | 650.5 INR |
| Bid | 628.05 INR x 0 |
| Ask | 628 INR x 0 |
| Day's Range | 627.05 - 654.9 INR |
| 52 Week Range | 502 - 778.9 INR |
| Volume | 901.63K INR |
| Avg. Volume | 466.42K INR |
| Market Cap | 112.52B INR |
| Beta (5Y Monthly) | 0.412328 |
| PE Ratio (TTM) | 16.033691 |
| EPS (TTM) | 70.93 INR |
| Forward Dividend & Yield | 7.5 (1.20%) |
| Ex-Dividend Date | February 21, 2023 |
| 1y Target Est | 1048.43 INR |
NATCOPHARM.NS Valuation Measures
| Enterprise Value | 103.2B INR |
| Trailing P/E | 16.033691 |
| Forward P/E | 15.221711 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.156363 |
| Price/Book (mrq) | 2.352668 |
| Enterprise Value/Revenue | 3.812 |
| Enterprise Value/EBITDA | 10.698 |
Trading Information
NATCO Pharma Limited Stock Price History
| Beta (5Y Monthly) | 0.412328 |
| 52-Week Change | -4.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 778.9 INR |
| 52 Week Low | 502 INR |
| 50-Day Moving Average | 604.09 INR |
| 200-Day Moving Average | 579.02 INR |
NATCOPHARM.NS Share Statistics
| Avg. Volume (3 month) | 466.42K INR |
| Avg. Daily Volume (10-Days) | 539.31K INR |
| Shares Outstanding | 179.11M |
| Float | 82.58M |
| Short Ratio | N/A |
| % Held by Insiders | 51.24% |
| % Held by Institutions | 19.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 5.5 |
| Trailing Annual Dividend Yield | 0.85% |
| 5 Year Average Dividend Yield | 93.00% |
| Payout Ratio | 0.14039999 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 26.42% |
| Operating Margin (ttm) | 29.58% |
| Gross Margin | 76.82% |
| EBITDA Margin | 35.63% |
Management Effectiveness
| Return on Assets (ttm) | 9.29% |
| Return on Equity (ttm) | 15.65% |
Income Statement
| Revenue (ttm) | 27.07B INR |
| Revenue Per Share (ttm) | 148.28 INR |
| Quarterly Revenue Growth (yoy) | 50.10% |
| Gross Profit (ttm) | 21.84B INR |
| EBITDA | 9.65B INR |
| Net Income Avi to Common (ttm) | 7.15B INR |
| Diluted EPS (ttm) | 39.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.62B INR |
| Total Cash Per Share (mrq) | 63.67 INR |
| Total Debt (mrq) | 1.67B INR |
| Total Debt/Equity (mrq) | 3.42 INR |
| Current Ratio (mrq) | 4.392 |
| Book Value Per Share (mrq) | 267.016 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 8.49B INR |
| Levered Free Cash Flow (ttm) | 5.8B INR |
Profile of NATCO Pharma Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | NATCO House |
| ZIP | 500034 |
| Phone | 91 40 2354 7532 |
| Website | https://www.natcopharma.co.in |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF; and agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Q&A For NATCO Pharma Limited Stock
What is a current NATCOPHARM.NS stock price?
NATCO Pharma Limited NATCOPHARM.NS stock price today per share is 975 INR.
How to purchase NATCO Pharma Limited stock?
You can buy NATCOPHARM.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NATCO Pharma Limited?
The stock symbol or ticker of NATCO Pharma Limited is NATCOPHARM.NS.
Which industry does the NATCO Pharma Limited company belong to?
The NATCO Pharma Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does NATCO Pharma Limited have in circulation?
The max supply of NATCO Pharma Limited shares is 179.12M.
What is NATCO Pharma Limited Price to Earnings Ratio (PE Ratio)?
NATCO Pharma Limited PE Ratio is 13.74594700 now.
What was NATCO Pharma Limited earnings per share over the trailing 12 months (TTM)?
NATCO Pharma Limited EPS is 70.93 INR over the trailing 12 months.
Which sector does the NATCO Pharma Limited company belong to?
The NATCO Pharma Limited sector is Healthcare.
NATCO Pharma Limited NATCOPHARM.NS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}